Loading company…
Ruibosi is a Beijing biotech firm developing stem cell technology and biopharmaceutical products for nerve and tissue repair.
Based in Beijing, China and founded in 2016, Beijing Darwin Cell Biotechnology Co., Ltd., trading as Ruibosi, works on stem cells and biopharmaceutical development, including drugs for nerve and cartilage repair. The company holds 6 intellectual property patents and was recognized as a National High-tech Enterprise in 2022. In December 2025 it raised a series C+ round from new investor Wuhan Optical Valley Financial Holding Group and returning investor THG Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in